This review summarizes currently available thrombolytic agents, adjunctive therapies, and future developments for the management of acute myocardial infarction.
No takes yet. Share an insight, caveat, or question.
Provides clinicians an overview of thrombolytics in AMI; leaves open optimal integration of future agents pending new trials.
McKenzie et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: